A Case of Serotonin Syndrome Caused by Venlafaxine and Lithium

Serotonin syndrome occurred under treatment with average dose of Venlafaxine and lithium in a 50 year-old female patient with a history of sensitiveness to SSRIs. Plasma levels of Venlafaxine and its metabolite were within reference range. Parmacogenetic evaluation indicated normal metabolic pathway...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pharmacopsychiatry 1997-11, Vol.30 (6), p.272-273
Hauptverfasser:	Mekler, G., Woggon, B.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antidepressive Agents, Second-Generation - adverse effects Antimanic Agents - adverse effects Biological and medical sciences Bipolar Disorder - drug therapy Case Reports Central Nervous System Diseases - chemically induced Cyclohexanols - adverse effects Drug Interactions Drug toxicity and drugs side effects treatment Female Humans Lithium Compounds - adverse effects Medical sciences Middle Aged Pharmacology. Drug treatments Serotonin Uptake Inhibitors - adverse effects Syndrome Toxicity: nervous system and muscle Venlafaxine Hydrochloride
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Serotonin syndrome occurred under treatment with average dose of Venlafaxine and lithium in a 50 year-old female patient with a history of sensitiveness to SSRIs. Plasma levels of Venlafaxine and its metabolite were within reference range. Parmacogenetic evaluation indicated normal metabolic pathway.
ISSN:	0176-3679 1439-0795
DOI:	10.1055/s-2007-979507